- Steve Grasso is a Regular on the Top-Rated CNBC Show “Fast Money” and Routinely Speaks at a Multitude of Investment Conferences Across the United States
- Fueled By Today’s Announcement, Shares of RWB Stock Surged Another 13% Extending its Current Bull Flag Breakout
Steve Grasso is well known throughout the financial community for his role at CNBC as a market analyst. Steve is a regular on the top-rated CNBC show Fast Money, which airs daily Monday to Friday and boasts an average daily viewership that currently exceeds 250,000.
In addition to his roles at CNBC, Steve regularly speaks at a multitude of investment conferences across the United States and also takes part in business round tables, which include many influential investors and business leaders. The round table discussions provide Steve with a platform to addresses a broad range of market-related issues, including the effects of regulation and the political process on equities.
“Steve has been assisting the company for some time, and we are pleased that he has agreed to take an expanded role as a business advisor. We believe Mr. Grasso’s significant experience in the financial markets coupled with his relationships in the Healthcare and Life Sciences industries will be a great asset to us as we move forward with our expansion plans in the U.S.,” commented Red White & Bloom Chairman and CEO Brad Rogers.
Steven Grasso began his career on the floor of the New York Stock Exchange in 1993. He joined Stuart Frankel & Co. as an institutional sales trader in 1999. As Director of Institutional Sales for Stuart Frankel & Co., Steven has worked closely with some of the largest mutual funds, pension funds, insurance companies, and hedge funds in the world directly from the floor of the Stock Exchange. Over his 27-year career, Steven has actively participated in various Stock Exchange committees ranging from allocating new listings to designated market makers to developing standardized tests that the floor community uses for continuing education. Steven closely follows the Washington D.C./Markets connection, using his extensive Capitol Hill and SEC relationships to better inform his clients on policy changes and regulation.
This U.S. Cannabis Stock Appears to Be Way Undervalued and May Actually Benefit From a Second Wave of the Pandemic
RWB Stock Price Action & Chart
Shares of Red White & Bloom’s CSE listed RWB stock closed today’s trading session up another 13.1% finishing the day at $1.12 per share. South of the border, the company’s U.S. listed RWBYF stock closed the day at $0.81, up 10.4%.
Following the initial surge higher after the company’s IPO in early June, shares of RWB consolidated beautifully over the past month, forming a bullish flag chart formation. As you’ll see via the chart below, RWB appears to have blown through the upper resistance trendline on a substantial increase in volume, thus confirming a potential breakout and indicating the resumption of its uptrend. With the recent sector-wide surge in U.S. multi-state operators (MSOs) led by Trulieve (CSE: TRUL) (OTCQX: TCNNF), investors should expect RWB stock to follow suit and with RWB’s current low valuation relative to its peers, the potential for outsized gains like highly likely.
Investor Research Links:
- CDN Listing | CSE: RWB
- U.S. Listing | OTCQX: RWBYF
- Website | IR Website | Investor Deck | RWB Chart | RWB Email Alerts
Red White & Bloom is a paid client of The Cannabis Investor. The Cannabis Investor holds a position in RWB.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.